Buy Recommendation Issued On LYEL By H.C. Wainwright
Source: KlickAnalytics
2025-12-09 06:15:06 ET
Historical Analyst Recommendations
Latest 10 recommendationsFull story available on KlickAnalytics.com
Lyell Immunopharma Inc.
NASDAQ: LYEL
LYEL Trading
18.57% G/L:
$25.80 Last:
114,088 Volume:
$23.40 Open:
LYEL Latest News
March 09, 2026 08:00:00 am
Lyell Immunopharma Announces Closing of Additional $50 Million Tranche of Equity Private Placement and Appointment of Smital Shah as Chief Financial and Business Officer
February 23, 2026 08:00:00 am
Lyell Immunopharma Announces Participation in March Investor Conferences
February 12, 2026 07:30:00 am
Lyell Immunopharma Announces Initiation of Patient Dosing in First-of-Its-Kind Phase 3 Head-To-Head CAR T-Cell Clinical Trial in Aggressive Large B-Cell Lymphoma
December 24, 2025 06:00:00 am
Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge
LYEL Stock Data
$503,932,654
12,184,349
0.5%
11
N/A
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
